LABORATORIOS FARMACEUTICOS ROVI - stock earnings
ROVI.MC Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | 52.2 million EUR | 214.0 million EUR |
2023Q2 | 19.2 million EUR | 179.2 million EUR |
2023Q1 | 47.5 million EUR | 201.6 million EUR |
2022Q4 | 78.2 million EUR | 242.2 million EUR |
2022Q3 | 40.9 million EUR | 195.1 million EUR |
2022Q2 | 27.6 million EUR | 174.8 million EUR |
2022Q1 | 53.0 million EUR | 205.6 million EUR |
2021Q4 | 54.1 million EUR | 185.2 million EUR |
2021Q3 | 47.9 million EUR | 173.5 million EUR |
2021Q2 | 27.2 million EUR | 159.5 million EUR |
2021Q1 | 23.8 million EUR | 130.5 million EUR |
2020Q4 | 14.2 million EUR | 117.8 million EUR |
2020Q3 | 17.2 million EUR | 111.0 million EUR |
2020Q2 | 15.7 million EUR | 90.2 million EUR |
2020Q1 | 13.9 million EUR | 101.0 million EUR |
2019Q4 | 8.6 million EUR | 110.5 million EUR |
2019Q3 | 14.5 million EUR | 93.2 million EUR |
2019Q2 | 9.3 million EUR | 95.4 million EUR |
2019Q1 | 6.9 million EUR | 82.2 million EUR |
2018Q4 | 2.2 million EUR | 84.3 million EUR |
2018Q3 | 8.1 million EUR | 72.6 million EUR |
2018Q2 | 712000 EUR | 70.5 million EUR |
2018Q1 | 6.8 million EUR | 75.8 million EUR |
2017Q4 | 221000 EUR | 72.2 million EUR |
2017Q3 | 1.3 million EUR | 64.7 million EUR |
2017Q2 | 9.4 million EUR | 71.3 million EUR |
2017Q1 | 6.4 million EUR | 67.5 million EUR |
2016Q4 | 4.6 million EUR | 73.7 million EUR |
2016Q3 | 3.5 million EUR | 62.6 million EUR |
2016Q2 | 8.6 million EUR | 68.2 million EUR |
2016Q1 | 9.4 million EUR | 60.7 million EUR |
2015Q4 | 3.3 million EUR | 68.4 million EUR |
2015Q3 | 2.9 million EUR | 56.4 million EUR |
2015Q2 | 7.1 million EUR | 60.5 million EUR |
2015Q1 | 6.5 million EUR | 60.8 million EUR |
2014Q4 | 4.3 million EUR | 64.8 million EUR |
2014Q3 | 4.9 million EUR | 57.0 million EUR |
2014Q2 | 9.0 million EUR | 58.7 million EUR |
2014Q1 | 5.9 million EUR | 57.6 million EUR |
2013Q4 | 4.3 million EUR | 56.7 million EUR |
2013Q3 | 4.8 million EUR | 51.3 million EUR |
2013Q2 | 8.5 million EUR | 55.8 million EUR |
2013Q1 | 5.3 million EUR | 53.8 million EUR |
2012Q4 | 6.6 million EUR | 97.0 million EUR |
2012Q3 | 3.7 million EUR | 48.7 million EUR |
2012Q2 | 7.7 million EUR | 53.9 million EUR |
2012Q1 | 5.3 million EUR | 50.9 million EUR |
2011Q4 | 5.3 million EUR | 88.8 million EUR |
2011Q3 | 2.9 million EUR | 44.3 million EUR |
2011Q2 | 8.0 million EUR | 49.1 million EUR |
2011Q1 | 4.9 million EUR | 46.8 million EUR |
2010Q4 | -67000 EUR | 44.2 million EUR |
2010Q3 | 5.7 million EUR | 41.7 million EUR |
2010Q2 | 13.9 million EUR | 39.4 million EUR |
2010Q1 | 5.0 million EUR | 33.3 million EUR |
2009Q4 | ? EUR | 40.7 million EUR |
2009Q3 | ? EUR | 40.7 million EUR |
2009Q2 | ? EUR | 30.2 million EUR |
2009Q1 | ? EUR | 30.2 million EUR |
2008Q4 | ? EUR | 34.3 million EUR |
2008Q3 | ? EUR | 34.3 million EUR |
2008Q2 | ? EUR | 29.5 million EUR |
2008Q1 | ? EUR | 29.5 million EUR |
2007Q4 | ? EUR | 16.3 million EUR |
2007Q2 | ? EUR | 20.1 million EUR |
2007Q1 | ? EUR | 20.1 million EUR |
ROVI.MC Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 197.0 million EUR | 837.1 million EUR |
2022 | 199.7 million EUR | 817.7 million EUR |
2021 | 153.1 million EUR | 648.7 million EUR |
2020 | 61.1 million EUR | 420.0 million EUR |
2019 | 39.3 million EUR | 381.3 million EUR |
2018 | 17.9 million EUR | 303.2 million EUR |
2017 | 17.2 million EUR | 275.6 million EUR |
2016 | 26.1 million EUR | 265.2 million EUR |
2015 | 19.8 million EUR | 246.0 million EUR |
2014 | 24.1 million EUR | 238.0 million EUR |
2013 | 23.0 million EUR | 217.6 million EUR |
2012 | 19.5 million EUR | 201.9 million EUR |
2011 | 18.1 million EUR | 184.7 million EUR |
2010 | 24.6 million EUR | 158.6 million EUR |
2009 | 23.1 million EUR | 115.2 million EUR |
2008 | 23.5 million EUR | 127.5 million EUR |
2007 | 15.0 million EUR | 100.7 million EUR |
2006 | 5.1 million EUR | 78.6 million EUR |
2005 | 912.1 billion EUR | 7.8 trillion EUR |
2004 | 1.6 billion EUR | 7.1 billion EUR |
2003 | ? EUR | 48.1 million EUR |
ROVI.MC
Price: €79.60
Dividend Yield: 0.01%
Forward Dividend Yield: 1.32%
Payout Ratio: 29.03%
Dividend Per Share: 1.05 EUR
Earnings Per Share: 3.20 EUR
P/E Ratio: 17.96
Exchange: MCE
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 4.2 billion
Average Dividend Frequency: 1
Years Paying Dividends: 16
DGR3: 24.13%